AzTrials
AzTrials

Cerebral PalsyFMSNCT05145231

valıdıty and relıabılıty of the turkısh versıon of the functıonal mobılıty Scale ın ındıvıduals wıth Cerebral Palsy

An observational study of Cerebral Palsy, run by Nursena Güçlü at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cerebral palsy (CP) describes a group of persistent disorders in movement and postural development that cause activity limitation, attributed to non-progressive disturbances occurring in the developing fetal or infant brain. Read more about this study

Who is it for?
Ages 4 to 18 years
Conditions the study is for
Cerebral Palsy
What is being tested?
observational
How many people
83 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Sep 2021to 20 May 2022
How long will I take part?
14 Days
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Patients aged 4-18 years diagnosed with cerebral palsy

Who may be able to join

  • 4 to 18 years of age
  • Being diagnosed with cerebral palsy
  • The GMFCS level was determined to be between I-IV.

Who cannot join

  • The parent who will answer the form does not know Turkish.
  • Performing orthopedic surgery and botulinum toxin injection in the previous six months.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Yeni Kurtuluş Özel Eğitim Ve Rehabilitasyon Merkezi

    Ankara, Altındağ, 06230

Other trials in Turkey (Türkiye)

About this study

Official title: valıdıty and relıabılıty of the turkısh versıon of the functıonal mobılıty Scale ın ındıvıduals wıth Cerebral Palsy (Fms)

Cerebral palsy (CP) describes a group of persistent disorders in movement and postural development that cause activity limitation, attributed to non-progressive disturbances occurring in the developing fetal or infant brain.

Motor disorders of cerebral palsy are often accompanied by sensory, perception, cognition, communication and behavioral disorders due to epilepsy and secondary musculoskeletal problems.(Rosenbaum et al. 2007) Within the ICF, body functions are the physiological functions of body systems and anatomical parts of the body, such as body structures, organs, limbs, and components.

Read more

Disorders are problems that appear as a significant deviation or loss in body functions or structure. The primary injury in CP is a brain lesion resulting from an upper motor neuron lesion that is thought to have a number of positive and negative features. Positive traits include spasticity, hyperreflexia, and co-contraction, while negative traits include weakness, loss of selective motor control, and balance and coordination deficits.

The aim of the study is to examine the validity and reliability of the Turkish version of the Functional Mobility Scale (FMS) in individuals with cerebral palsy.

Read the detailed description

GROSS MOTOR FUNCTİON CLASSİFİCATİON SYSTEM (GMFCS):

Level I: Walks without restrictions. Level II: Walks with restrictions. Level III: Walks using hand-held mobility devices. Level IV: Self-movement is limited. Can use a motorized mobility vehicle. Level V: Transported in a manual wheelchair. Differences Between Levels

Differences Between Levels I and II:

Compared to children/teens in Level I, children/teenagers in Level II have limitations in walking and balance. They may need hand-held mobility devices when they first learn to walk. They can use a wheeled mobility vehicle for long distance trips outside the home and in the community. They need the use of handrails when going up and down stairs. He does not have the ability to run and jump.

Differences Between Levels II and III:

Children and teenagers at Level II can walk without a hand-held mobility device after age 4 (although they prefer to use it occasionally). Children and youth in Level III use hand-held mobility devices to walk indoors and use wheeled mobility devices outside the home and in the community.

Differences Between Level III and IV:

Children and teenagers in Level III sit on their own or need very nervous external support to sit, are more independent in standing displacements, and walk with a hand-held mobility device. Children/teens at Level IV are functional seated (usually supported), but self-mobility is limited. Children and young people in Level IV are mostly transported in a manual wheelchair or use a motorized mobility vehicle.

Differences Between Levels IV and V:

Children and teenagers at Level V have severe limitations in bass and trunk control and need extensive technological and physical assistance. Self-mobility is gained only when the child/youth learns how to use a motorized wheelchair (2).

PEDİATRİC EVALUATİON OF DİSABİLİTY INVENTORY (PEDI):

Evaluates activities of daily living (self-care, mobility, social function) in children aged between 6 months and 7.5 years. PEDI is a comprehensive clinical assessment tool that assesses children's functional ability and performance. The first section, the Functional Skills Section, consists of 197 items and is a direct measurement of the child's functional abilities. In this section, the Self-Care subsection consists of 73 items, the Mobility subsection 59 and the Social Functions subsection 65 items. The child is given points as "0=cannot" and "1=can" for the items in this section. At the end of each subsection, the scores of that section are summed up and the functional skills (FB) total score is obtained by adding the scores of the subsections. The second and third sections evaluate the help and form of assistance from caregivers. It occurs in self-care, mobility, and social function items. Evaluation with the help of the caregiver is graded as independent, observation, minimum, moderate, maximum, complete. Adaptation evaluation is examined in 4 categories as no adaptation, adaptations for the child, rehabilitation tools and intensive adaptation. In this study, the mobility section will be used (3).

ABILOCO- KIDS:

It is a valid and reliable locomotion abilities scale defined on 10 items. ABILOCO-KIDS, which measures mobility, was translated into Turkish and applied. ABİLOCO-kids questionnaire consisting of ten questions was filled according to the information given by the parents. Questions are evaluated on a five-point scale. Impossible, difficult, easy, (unobserved activity). It can be applied to children aged 5 and over. (4)

FUNCTIONAL MOBILITY SCALE (FMS):

FMS classifies functional mobility in children with CP by grading the ability to walk at three specific distances, 5, 50, and 500 meters, according to the need for assistive devices. The scale includes various assistive devices such as wheelchairs, walkers, crutches and sticks, and also includes walking without the need for assistive devices. It uses a six-point ordinal scale (1-6) to rate the assistance needed at each distance reflecting distances from home, school, and community.

6 points, Independent on all surfaces. It does not use any walking aids or require the assistance of another person when walking on all surfaces, including uneven floors. (sidewalks etc. and in a crowded environment.)

5 points, Independent on flat surfaces. Does not use walking aids or need someone else's help. It needs handrails for stairs.

4 points, uses a cane (one or two). Walks without the help of another person.

3 points uses crutches without someone else's help.

2 points use walker without anyone else's help.

1 point, Uses a wheelchair. Can stop for transfers, take a few steps assisted by another person or using a walker.

C = Crawling: Child crawls (5m) to be able to move around the house.

N = not valid : For example, the child does not complete the distance ( 500 m ) .(1)

Conditions
Cerebral Palsy
Being tested
observational
Keywords
serebral palsi, GMFCS, Functional Mobility Scale, Abiloco-kids
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • observationalOther

    The scales will be filled by asking the family.

Study groups in NCT05145231
Study groupRoleWhat they receive
grup 1GMFCS PEDİ ABİLOCO-KİDS FMS
Receives: Other: observational

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. functional mobility scale

    6 points, Independent on all surfaces. It does not use any walking aids or require the assistance of another person when walking on all surfaces, including uneven floors. (sidewalks etc. and in a crowded environment.)

    5 points, Independent on flat surfaces. Does not use walking aids or need someone else's help. It needs handrails for stairs.

    4 points, uses a cane (one or two). Walks without the help of another person.

    3 points uses crutches without someone else's help.

    2 points use walker without anyone else's help.

    1 point, Uses a wheelchair. Can stop for transfers, take a few steps assisted by another person or using a walker.

    C = Crawling: Child crawls (5m) to be able to move around the house.

    N = not valid : For example the child does not complete the distance ( 500 m ) .

    Measured: 2 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Dec 2021
  2. Study start15 Sep 2021
  3. Primary completion30 Apr 2022
  4. Study completion20 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
83 participants (actual)
Target duration
14 Days
IDs, dates and publications
ClinicalTrials.gov ID
NCT05145231
Sponsor's protocol ID
Kirikkaleüniversity3
Acronym
FMS
Status last verified
Sep 2024
First submitted
1 Oct 2021
Last updated
27 Sep 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cerebral Palsy, run by Nursena Güçlü at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

functional mobility scale (time frame: 2 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in